Companies in #Cancer Diagnostics
Found 2 companies operating in this sector.
Advanced Biomed is a Nevada-incorporated medical technology company headquartered in Tainan, Taiwan that is developing microfluidic biochip-based in vitro diagnostic platforms for cancer and personalized healthcare. The company closed a $6.56 million initial public offering on July 17, 2026 (disclosed via Form 8-K, accession 0001213900-26-079233), regaining Nasdaq listing compliance after a July 2025 notice that the bid price had closed below the $1.00 minimum-bid threshold for continued listing. Trading on Nasdaq under the symbol ADVB, the company had previously executed a 1-for-20 reverse stock split to consolidate its share count.
Caris Life Sciences is a leading patient-centric next-generation AI TechBio company and precision medicine pioneer. The company operates the Caris Assure and Caris Discovery platforms for molecular profiling of cancer patients, enabling oncologists to match patients to targeted therapies and clinical trials.